Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

Autor: Kemp SA; Division of Infection and Immunity, University College London, London, UK., Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Jahun A; Department of Pathology, University of Cambridge, Cambridge, UK., Hosmillo M; Department of Pathology, University of Cambridge, Cambridge, UK., Rees-Spear C; Division of Infection and Immunity, University College London, London, UK., Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK., Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK., Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Canterbury, UK., Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Blane E; Department of Medicine, University of Cambridge, Cambridge, UK., Modis Y; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Leigh KE; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Briggs JAG; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Bioresource, Cambridge, UK., Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; FES-Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico., Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA., Goldstein RA; Division of Infection and Immunity, University College London, London, UK., Smielewska A; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK., Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge, UK., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Illingworth CJR; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.

Publikováno v: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E23.

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation.

Autor: Kemp SA; Division of Infection and Immunity, University College London, London, UK., Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir R; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Ferreira I; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Jahun A; Department of Pathology, University of Cambridge, Cambridge., Hosmillo M; Department of Pathology, University of Cambridge, Cambridge., Rees-Spear C; Division of Infection and Immunity, University College London, London, UK., Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, UK., Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, UK., Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, UK., Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Blane E; Department of Medicine, University of Cambridge, Cambridge, UK., Briggs J; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., van GM; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Smith K; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust., Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital., Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital., Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA., Goldstein RA; Division of Infection and Immunity, University College London, London, UK., Smielewska A; Department of Pathology, University of Cambridge, Cambridge.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust., Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrookes' Hospital, Cambridge, UK., Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Illingworth C; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Africa Health Research Institute, Durban, South Africa.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2020 Dec 29. Date of Electronic Publication: 2020 Dec 29.